NCT01912937View on ClinicalTrials.gov

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries:

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2017

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Angioplasty treatment with the CVI Drug-coated Balloon (DCB)

Angioplasty treatment with the CVI Paclitaxel-Coated, Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter (CVI Paclitaxel-coated PTA Catheter)

Trial Locations (2)

Unknown

Auckland City Hospital, Auckland

Clinical Trials New Zealand, Hamilton

All Listed Sponsors
lead

Spectranetics Corporation

INDUSTRY

NCT01912937 - Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: | Biotech Hunter | Biotech Hunter